This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Janssen Pharmaceuticals, Inc.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Ewa Wajs - Innovator in Depression Treatment
Introduction
Ewa Wajs is a notable inventor based in Beerse, Belgium. She has made significant contributions to the field of mental health, particularly in the treatment of depression. Her innovative work has led to the development of a patented method that utilizes esketamine for effective treatment.
Latest Patents
Ewa Wajs holds a patent for her invention titled "Esketamine for the treatment of depression." This patent outlines methods for maintaining stable remission or response in patients suffering from depression. The invention emphasizes the importance of administering a therapeutically effective amount of esketamine during an initial phase and continuing this treatment for at least five months. Additionally, it provides methods for long-term treatment, ensuring that patients receive clinically proven safe and effective dosages for at least six months. The patent addresses major depressive disorder and treatment-resistant depression, showcasing its potential impact on mental health care.
Career Highlights
Ewa Wajs is associated with Janssen Pharmaceuticals, Inc., where she applies her expertise in developing innovative treatments. Her work is pivotal in advancing therapeutic options for individuals struggling with depression.
Collaborations
Ewa collaborates with esteemed colleagues, including David Wood Hough and Jaskaran Singh. Their combined efforts contribute to the ongoing research and development of effective mental health treatments.
Conclusion
Ewa Wajs is a pioneering inventor whose work in the treatment of depression through esketamine has the potential to transform mental health care. Her contributions are vital in providing new hope for patients facing these challenges.